Affymetrix Inc (AFFX) 14.01 $AFFX
Global Biochip Industry
PR Newswire - Tue Jun 07, 5:40PM CDT
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -
A: 45.36 (-0.73), AFFX: 14.01 (+0.02)
Uptrend Call Working As Affymetrix Stock Rises 48.1% (AFFX)
Comtex SmarTrend(R) - Mon Jun 06, 1:03PM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Has Returned 48.1% Since SmarTrend Recommendation (AFFX)
Comtex SmarTrend(R) - Fri May 27, 1:03PM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Shares Up 48.1% Since SmarTrend's Buy Recommendation (AFFX)
Comtex SmarTrend(R) - Fri May 20, 12:31AM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Up 48.1% Since SmarTrend Uptrend Call (AFFX)
Comtex SmarTrend(R) - Thu May 05, 12:44AM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 6 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders
BusinessWire - Thu Mar 31, 12:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix, Inc. (NASDAQ: AFFX), a leading provider of cellular and genetic analysis products, today announced that Thermo Fisher has completed its previously announced acquisition of Affymetrix for $14.00 per share in cash, for a total purchase price of approximately $1.3 billion. Completion of the transaction follows approval of the merger agreement by Affymetrix stockholders at the special meeting held today.
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02)
WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600
PR Newswire - Wed Mar 30, 5:24PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, April 1:
WBMD: 62.90 (-1.28), TMO: 151.80 (-2.35), SUNE: 0.34 (unch), SCLN: 13.63 (-0.36), MHFI: 107.92 (+1.16), AFFX: 14.01 (+0.02)
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Affymetrix, Inc.
PR Newswire - Wed Mar 30, 11:28AM CDT
Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, case no. 3:16-cv-00921, on behalf of shareholders of Affymetrix, Inc. ("Affymetrix" or the "Company"
(NasdaqGS:AFFX) who held Affymetrix securities on the record date, February 18, 2016, and have been harmed by Affymetrix's and its board of directors' (the "Board" alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" in connection with the proposed sale of the Company to Thermo Fisher Scientific Inc. ("Thermo Fisher".
AFFX: 14.01 (+0.02)
Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Origin Withdraws $17.00 Per Share All-Cash Offer for Affymetrix
BusinessWire - Mon Mar 28, 5:15PM CDT
Origin Technologies Corporation, LLC ("Origin", a newly created entity owned by a group of former Affymetrix executives for the purpose of privatizing Affymetrix, Inc. ("Affymetrix", NASDAQ: AFFX), today announced that, following discussions with the Affymetrix Board of Directors and its advisors, it has withdrawn its proposal to acquire Affymetrix for $17.00 per share in cash.
AFFX: 14.01 (+0.02)
Thermo Fisher Scientific Agrees with Affymetrix that Merger Agreement Remains Superior
BusinessWire - Mon Mar 28, 2:11PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today issued the following statement regarding Affymetrix, Inc.'s (NASDAQ: AFFX) press release dated March 28, 2016:
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02)
Affymetrix Board of Directors Reaffirms Support of Merger with Thermo Fisher
BusinessWire - Mon Mar 28, 1:16PM CDT
--Recommends against Origin Proposal
AFFX: 14.01 (+0.02)
Affymetrix to Engage in Discussions With Origin Technologies
BusinessWire - Wed Mar 23, 8:58PM CDT
Affymetrix, Inc. (NASDAQ: AFFX, "Affymetrix" or the "Company" today announced that the Company's Board of Directors has informed Origin Technologies Corporation, LLC ("Origin" that the Company will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire the Company for $17.00 per share in an all-cash transaction.
AFFX: 14.01 (+0.02)
Global Biochip Industry
PR Newswire - Tue Jun 07, 5:40PM CDT
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -
A: 45.36 (-0.73), AFFX: 14.01 (+0.02)
Uptrend Call Working As Affymetrix Stock Rises 48.1% (AFFX)
Comtex SmarTrend(R) - Mon Jun 06, 1:03PM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Has Returned 48.1% Since SmarTrend Recommendation (AFFX)
Comtex SmarTrend(R) - Fri May 27, 1:03PM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Shares Up 48.1% Since SmarTrend's Buy Recommendation (AFFX)
Comtex SmarTrend(R) - Fri May 20, 12:31AM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 7 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Affymetrix Up 48.1% Since SmarTrend Uptrend Call (AFFX)
Comtex SmarTrend(R) - Thu May 05, 12:44AM CDT
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 6 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.
AFFX: 14.01 (+0.02)
Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders
BusinessWire - Thu Mar 31, 12:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix, Inc. (NASDAQ: AFFX), a leading provider of cellular and genetic analysis products, today announced that Thermo Fisher has completed its previously announced acquisition of Affymetrix for $14.00 per share in cash, for a total purchase price of approximately $1.3 billion. Completion of the transaction follows approval of the merger agreement by Affymetrix stockholders at the special meeting held today.
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02)
WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600
PR Newswire - Wed Mar 30, 5:24PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, April 1:
WBMD: 62.90 (-1.28), TMO: 151.80 (-2.35), SUNE: 0.34 (unch), SCLN: 13.63 (-0.36), MHFI: 107.92 (+1.16), AFFX: 14.01 (+0.02)
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Affymetrix, Inc.
PR Newswire - Wed Mar 30, 11:28AM CDT
Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, case no. 3:16-cv-00921, on behalf of shareholders of Affymetrix, Inc. ("Affymetrix" or the "Company"
(NasdaqGS:AFFX) who held Affymetrix securities on the record date, February 18, 2016, and have been harmed by Affymetrix's and its board of directors' (the "Board" alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" in connection with the proposed sale of the Company to Thermo Fisher Scientific Inc. ("Thermo Fisher". AFFX: 14.01 (+0.02)
Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Origin Withdraws $17.00 Per Share All-Cash Offer for Affymetrix
BusinessWire - Mon Mar 28, 5:15PM CDT
Origin Technologies Corporation, LLC ("Origin"
, a newly created entity owned by a group of former Affymetrix executives for the purpose of privatizing Affymetrix, Inc. ("Affymetrix", NASDAQ: AFFX), today announced that, following discussions with the Affymetrix Board of Directors and its advisors, it has withdrawn its proposal to acquire Affymetrix for $17.00 per share in cash. AFFX: 14.01 (+0.02)
Thermo Fisher Scientific Agrees with Affymetrix that Merger Agreement Remains Superior
BusinessWire - Mon Mar 28, 2:11PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today issued the following statement regarding Affymetrix, Inc.'s (NASDAQ: AFFX) press release dated March 28, 2016:
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02)
Affymetrix Board of Directors Reaffirms Support of Merger with Thermo Fisher
BusinessWire - Mon Mar 28, 1:16PM CDT
--Recommends against Origin Proposal
AFFX: 14.01 (+0.02)
Affymetrix to Engage in Discussions With Origin Technologies
BusinessWire - Wed Mar 23, 8:58PM CDT
Affymetrix, Inc. (NASDAQ: AFFX, "Affymetrix" or the "Company"
today announced that the Company's Board of Directors has informed Origin Technologies Corporation, LLC ("Origin" that the Company will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire the Company for $17.00 per share in an all-cash transaction. AFFX: 14.01 (+0.02)
